Evogene Ltd.

Regulatory Filings • Jun 3, 2020

_________ false

����� ��"�	2 381
EVOGENE LTD
Corporation no: 512838723	10571
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	03/06/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-057105	Time of broadcast: 14:01 13:59:58

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Evogene to Participate in CRISPR-IL Consortium to Provide end-to-end Artificial Intelligence System for Genome-Editing

PR_Evogene_CRISPR-IL_FINAL_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 22/04/2020
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: ofer.haviv@evogene.com   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Director of Legal Affairs & Company Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612001 Telephone: 08-9311901 Facsimile: 08-9466724 E-mail: sassi.masliah@evogene.com 1